NM_001001548.3:c.282-10A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001001548.3(CD36):​c.282-10A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.97 in 1,605,826 control chromosomes in the GnomAD database, including 756,819 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.93 ( 66006 hom., cov: 32)
Exomes 𝑓: 0.97 ( 690813 hom. )

Consequence

CD36
NM_001001548.3 intron

Scores

2
Splicing: ADA: 0.00001424
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.65

Publications

26 publications found
Variant links:
Genes affected
CD36 (HGNC:1663): (CD36 molecule (CD36 blood group)) The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014]
CD36 Gene-Disease associations (from GenCC):
  • platelet-type bleeding disorder 10
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 7-80661053-A-G is Benign according to our data. Variant chr7-80661053-A-G is described in ClinVar as Benign. ClinVar VariationId is 360754.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD36NM_001001548.3 linkc.282-10A>G intron_variant Intron 4 of 14 ENST00000447544.7 NP_001001548.1 P16671-1A4D1B1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD36ENST00000447544.7 linkc.282-10A>G intron_variant Intron 4 of 14 5 NM_001001548.3 ENSP00000415743.2 P16671-1

Frequencies

GnomAD3 genomes
AF:
0.928
AC:
141108
AN:
152092
Hom.:
65985
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.797
Gnomad AMI
AF:
0.997
Gnomad AMR
AF:
0.962
Gnomad ASJ
AF:
0.965
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.995
Gnomad FIN
AF:
0.981
Gnomad MID
AF:
0.975
Gnomad NFE
AF:
0.977
Gnomad OTH
AF:
0.946
GnomAD2 exomes
AF:
0.968
AC:
242906
AN:
250876
AF XY:
0.972
show subpopulations
Gnomad AFR exome
AF:
0.792
Gnomad AMR exome
AF:
0.978
Gnomad ASJ exome
AF:
0.960
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.980
Gnomad NFE exome
AF:
0.976
Gnomad OTH exome
AF:
0.974
GnomAD4 exome
AF:
0.974
AC:
1416422
AN:
1453616
Hom.:
690813
Cov.:
31
AF XY:
0.976
AC XY:
706224
AN XY:
723914
show subpopulations
African (AFR)
AF:
0.784
AC:
26092
AN:
33276
American (AMR)
AF:
0.976
AC:
43646
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.962
AC:
25096
AN:
26090
East Asian (EAS)
AF:
1.00
AC:
39599
AN:
39600
South Asian (SAS)
AF:
0.996
AC:
85719
AN:
86106
European-Finnish (FIN)
AF:
0.980
AC:
52333
AN:
53402
Middle Eastern (MID)
AF:
0.973
AC:
5585
AN:
5742
European-Non Finnish (NFE)
AF:
0.978
AC:
1080239
AN:
1104566
Other (OTH)
AF:
0.967
AC:
58113
AN:
60118
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
1540
3080
4621
6161
7701
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21450
42900
64350
85800
107250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.928
AC:
141181
AN:
152210
Hom.:
66006
Cov.:
32
AF XY:
0.930
AC XY:
69170
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.797
AC:
33051
AN:
41486
American (AMR)
AF:
0.962
AC:
14719
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.965
AC:
3350
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5157
AN:
5158
South Asian (SAS)
AF:
0.995
AC:
4804
AN:
4826
European-Finnish (FIN)
AF:
0.981
AC:
10419
AN:
10616
Middle Eastern (MID)
AF:
0.973
AC:
286
AN:
294
European-Non Finnish (NFE)
AF:
0.977
AC:
66491
AN:
68038
Other (OTH)
AF:
0.946
AC:
1995
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
465
929
1394
1858
2323
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
906
1812
2718
3624
4530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.944
Hom.:
40298
Bravo
AF:
0.920
Asia WGS
AF:
0.980
AC:
3408
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Platelet-type bleeding disorder 10 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.94
DANN
Benign
0.41
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000014
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3211892; hg19: chr7-80290369; API